Zymeworks(ZYME)
MIDDLETOWN, DE
BiotechnologyFocus: In Silico Biologics Development
Zymeworks is a life sciences company focused on In Silico Biologics Development.
OncologyImmunology
Funding Stage
PUBLIC
Employees
501-1000
Open Jobs
4
Pipeline & Clinical Trials
Phase 1
Clinical Trials (1)
NCT03821233A Dose Finding Study of ZW49 in Patients With HER2-Positive Cancers
Phase 1Phase 1
Clinical Trials (1)
NCT06555744A Study of ZW191 in Participants With Solid Tumors
Phase 1Phase 1
Clinical Trials (1)
NCT06523803A Study of ZW171 in Participants With Advanced or Metastatic Mesothelin-expressing Cancers
Phase 1Phase 1
Clinical Trials (1)
NCT07164313A Study of ZW251 in Participants With Advanced Solid Tumors
Phase 1Zanidatamab
Breast CancerClinical Trials (1)
NCT05035836A Phase 2 Single-Arm Open-Label Pilot Trial Evaluating Zanidatamab (ZW25) in Patients With Early Stage HER2/Neu Positive (HER2+) Breast Cancer (BC)
Phase 2Phase 2
Clinical Trials (1)
NCT04513665ZW25 in Women With Endometrial Cancers
Phase 2Futibatinib
Biliary Tract NeoplasmsOpen Jobs (4)
Clinical Data Manager (6-month contract)
Bellevue, WA
Research & Development1w ago
Medical Director, Clinical Development
Swords, Ireland; Cambridge, United Kingdom
Research & Development1w ago
Senior Manager, IT Applications (G&A)
Vancouver, Canada
General / Administrative2w ago
Senior Director, Business Development
Remote
General / Administrative5mo ago
Interview Prep Quick Facts
Portfolio: 6 clinical trials
SEC Filings: 2 available
Open Roles: 4 active jobs
Financials (FY2025)
Revenue
$76M82%
R&D Spend
$144M(189%)31%
Net Income
-$119MCash
$66MHiring Trend
Stable
4
Open Roles
+0
Added
-0
Filled/Removed
Based on last 4 crawl cycles